Importer of Controlled Substances Application: AndersonBrecon dba PCI Pharma Services; Correction, 37260 [2024-09785]
Download as PDF
<![CDATA[
37260
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
Controlled substance
Drug code
Hydrocodone .......................................................................................................................................................................
Levorphanol .........................................................................................................................................................................
Isomethadone ......................................................................................................................................................................
Meperidine ...........................................................................................................................................................................
Meperidine-intermediate-A ..................................................................................................................................................
Meperidine intermediate-B ..................................................................................................................................................
Meperidine intermediate-C ..................................................................................................................................................
Methadone ...........................................................................................................................................................................
Methadone intermediate ......................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..................................................................................................................
Morphine ..............................................................................................................................................................................
Oripavine .............................................................................................................................................................................
Thebaine ..............................................................................................................................................................................
Opium, raw ..........................................................................................................................................................................
Opium extracts ....................................................................................................................................................................
Opium fluid extract ..............................................................................................................................................................
Opium tincture .....................................................................................................................................................................
Opium, powdered ................................................................................................................................................................
Opium, granulated ...............................................................................................................................................................
Oxymorphone ......................................................................................................................................................................
Noroxymorphone .................................................................................................................................................................
Alfentanil ..............................................................................................................................................................................
Remifentanil .........................................................................................................................................................................
Sufentanil .............................................................................................................................................................................
Carfentanil ...........................................................................................................................................................................
Tapentadol ...........................................................................................................................................................................
Bezitramide ..........................................................................................................................................................................
Fentanyl ...............................................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols) the company
plans to import a synthetic cannabidiol
and a synthetic tetrahydrocannabinol.
No other activities for these drug codes
are authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register on
March 6, 2024, concerning an
application for an Importer of
Controlled Substances. The document
request removal of Dimethyltrytamine.
SUMMARY:
SUPPLEMENTARY INFORMATION:
In the Federal Register on March 6,
2024, in FR Doc No: 89 FR 16029, FR
No. 2024–04753, on pages 16029–16030
(2 pages), in the first column, remove
the controlled substance
Dimethltrytamine from the list to read
as follows:
Controlled substance
Drug
code
Schedule
[FR Doc. 2024–09811 Filed 5–3–24; 8:45 am]
Cocaine ........................
Methadone ....................
9041
9250
II
II
I
Marsha Ikner,
Acting Deputy Assistant Administrator.
Drug Enforcement Administration
[FR Doc. 2024–09785 Filed 5–3–24; 8:45 am]
BILLING CODE P
ddrumheller on DSK120RN23PROD with NOTICES1
I
DEPARTMENT OF JUSTICE
[Docket No. 1324]
Importer of Controlled Substances
Application: AndersonBrecon dba PCI
Pharma Services; Correction
Drug Enforcement
Administration, Justice.
ACTION: Notice of correction.
AGENCY:
VerDate Sep<11>2014
18:02 May 03, 2024
Jkt 262001
PO 00000
Frm 00101
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1357]
Bulk Manufacturer of Controlled
Substances Application: Pharmaron
Manufacturing Services (US) LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Correction
Marsha Ikner,
Acting Deputy Assistant Administrator.
BILLING CODE 4410–09–P
9193
9220
9226
9230
9232
9233
9234
9250
9254
9273
9300
9330
9333
9600
9610
9620
9630
9639
9640
9652
9668
9737
9739
9740
9743
9780
9800
9801
Schedule
Fmt 4703
Sfmt 4703
Pharmaron Manufacturing
Services (US) LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 5, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 5, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
SUMMARY:
E:\FR\FM\06MYN1.SGM
06MYN1
]]>Agencies
[Federal Register Volume 89, Number 88 (Monday, May 6, 2024)]
[Notices]
[Page 37260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09785]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1324]
Importer of Controlled Substances Application: AndersonBrecon dba
PCI Pharma Services; Correction
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of correction.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) published a document
in the Federal Register on March 6, 2024, concerning an application for
an Importer of Controlled Substances. The document request removal of
Dimethyltrytamine.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register on March 6, 2024, in FR Doc No: 89 FR
16029, FR No. 2024-04753, on pages 16029-16030 (2 pages), in the first
column, remove the controlled substance Dimethltrytamine from the list
to read as follows:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cocaine............................... 9041 II
Methadone............................. 9250 II
------------------------------------------------------------------------
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-09785 Filed 5-3-24; 8:45 am]
BILLING CODE P
